VCM
ELGX

Versant Capital Management’s Endologix Inc ELGX Stock Holding History

Versant Capital Management’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-7
Closed – – 1748
2017
Q4 		$0 Hold
7
– – ﹤0.01% 1712
2017
Q3 		$0 Buy
+7
New +$319 ﹤0.01% 1643

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Versant Capital Management's ELGX Position: Q1 2018 in Review

Versant Capital Management sold out of Endologix Inc (ELGX) in Q1 2018, closing a stake of 7 shares.

Versant Capital Management first reported a position in ELGX in Q3 2017 and held it in 2 quarters. The position peaked at $0 in Q4 2017. 97 funds tracked by Wall St. Rank hold ELGX as of Q1 2018.

  • Versant Capital Management reported no remaining Endologix Inc position as of Q1 2018 after selling out during the quarter.
  • Versant Capital Management sold 7 Endologix Inc shares in Q1 2018.
  • Versant Capital Management first reported a position in Endologix Inc in Q3 2017 and held it in 2 quarters.
  • Versant Capital Management's Endologix Inc position peaked at $0 in Q4 2017.
  • 97 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2018.

Based on Versant Capital Management's 13F filing for Q1 2018, filed 19 Apr 2018.